NL

Nisa Leung

Managing Partner, Qiming Venture Partners, Forbes Midas Lister

United States

Invests in

Locations:

  • Min Investment:

    $250,000.00
  • Max Investment:

    $15,000,000.00
  • Target Investment:

    $8,000,000.00

Investments

Thorough Future

Series A

Total Funding: $28M

GenEditBio

Seed

Total Funding: $90M

CureGenetics

Series A

Total Funding: $96M

Alamar Biosciences

Series A

Total Funding: $220M

Hope Medicine

Series B

Total Funding: $84M

Silicon Yi Technology

Series A

Total Funding: $4M

ACXEL Tech

Seed

Total Funding: $24M

Yanyin Technology

Seed

Total Funding:

Sanegene Bio

Series A

Total Funding: $120M

Congnitact

Series A

Total Funding:

CSR Biotech

Seed

Total Funding:

Atantares

Angel

Total Funding: $14M

Ailomics Therapeutics

Seed

Total Funding:

Complete Omics

Series A

Total Funding: $10M

Zeen Health

Seed

Total Funding: $6M

Joes Future Food

Series A

Total Funding:

Brise Pharma

Angel

Total Funding: $23M

1 Yong Cloud

Series B

Total Funding:

Caidya

Series D

Total Funding:

SinoUnited Health Clinic

Series B

Total Funding: $48M

Insyce

Series B

Total Funding: $22M

Bio-Link

Series A

Total Funding:

PureVision

Series A

Total Funding:

PlusLife Biotech

Series A

Total Funding: $15M

Core Medical

Series A

Total Funding: $4M

Intellinosis

Angel

Total Funding:

XellSmart

Seed

Total Funding: $12M

Weiqiang Medical

Series Unknown

Total Funding:

Insilico Medicine

Series B

Total Funding: $390M

Norm Medtech

Series B

Total Funding:

GluBio Therapeutics

Series A

Total Funding: $22M

GYENNO Technologies

Series B

Total Funding: $17M

Gaugene

Series A

Total Funding: $20M

Resunbio

Series A

Total Funding:

Purevision

Seed

Total Funding:

Yanshengchao

Seed

Total Funding:

Vistel

Series B

Total Funding: $9M

Belief Biomed

Series B

Total Funding: $84M

Curie.Bio

Series B

Total Funding:

Medilink Therapeutics

Series A

Total Funding: $120M

Tingsheng Technology

Series A

Total Funding: $16M

Prime Lifescience

Seed

Total Funding: $30M

Zhenge Biotech

Series B

Total Funding: $170M

DP Technology

Series B

Total Funding: $44M

Bioyond Tech

Seed

Total Funding: $8M

GenEdit

Angel

Total Funding: $18M

Structure Therapeutics

Series A

Total Funding: $140M

Genevide

Angel

Total Funding: $6M

Berry Oncology

Series A

Total Funding: $230M

BrainHealth

Series C

Total Funding: $72M

Health Biotech

Series B

Total Funding: $31M

Valgen Medtech

Series B

Total Funding: $190M

ZSHK Laboratories

Series A

Total Funding: $16M

Basecamp Bio

Angel

Total Funding: $14M

MediLink-Global

Series A

Total Funding: $37M

Kira Pharmaceuticals

Series A

Total Funding: $100M

dMed

Series A

Total Funding: $160M

Broncus Technologies

Series Unknown

Total Funding: $16M

InventisBio

Series D

Total Funding: $150M

New Horizon Health

Series B

Total Funding: $70M

DiNovA Medtech

Series C

Total Funding: $42M

Berry Genomics

Series B

Total Funding: $160M

Jacobio Pharmaceuticals

Series B

Total Funding: $100M

Tisenc

Series A

Total Funding: $18M

KeChow Pharma

Series C

Total Funding: $45M

ACEA BIO

Series Unknown

Total Funding: $71M

Schrödinger

Series E

Total Funding: $180M

Sino Biological

Series A

Total Funding: $45M

Wuxi Vision Pro

Series A

Total Funding: $18M

CMLabs

Series A

Total Funding: $31M

Venus MedTech

Series A

Total Funding: $32M

VR Medical

Series A

Total Funding: $9M

Qiagen Suzhou Translational Medicine

Series A

Total Funding: $26M

Zai Lab

Series A

Total Funding: $180M

SinoTau

Series B

Total Funding: $22M

Sinocelltech

Series A

Total Funding: $29M

CanSinoBIO

Series C

Total Funding: $110M

LIH Investment & Management

Series A

Total Funding: $18M

Shenogen Pharma Group

Series C

Total Funding: $67M

Nurotron Biotechnology

Series B

Total Funding: $24M

Zhejiang JFK

Angel

Total Funding:

Amoy Diagnostics

Series A

Total Funding: $11M

Mitralign

Series E

Total Funding: $58M

Beijing Richen-Force Science & Technology

Series B

Total Funding: $4M

Crown Bioscience

Series Unknown

Total Funding: $59M

Origene Technologies

Series C

Total Funding: $21M

Gan & Lee Pharmaceutical

Series A

Total Funding: $46M

Beijing GoodWill Technology

Series A

Total Funding: $4M

Novast

Series B

Total Funding: $80M

Aeonmed Medical Treatment

Series A

Total Funding: $4M

CITIC Pharmaceutical

Series D

Total Funding: $23M

Work Experience

  • Managing Partner

    2006

  • Member Board Of Directors

    2021

  • Investor

    2018

2014

  • Board Member

    2014

2016

  • Board Member

    2016

  • Board Member / Investor

    2019

  • Investor

    2024

  • Board Member

    2020

2022

  • Investor

    2022

  • Board Member

    2019